At a glance
- Originator Pfizer
- Class
- Mechanism of Action Dopamine D3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 31 Dec 2003 Discontinued - Preclinical for Psychotic disorders in USA (unspecified route)
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 07 Dec 2000 Preclinical development for Psychotic disorders in USA (Unknown route)